Tumor Biology

, Volume 36, Issue 11, pp 8861–8867 | Cite as

Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate

  • Mohd Farhan
  • Asim Rizvi
  • Imrana Naseem
  • S. M. Hadi
  • Aamir Ahmad
Research Article


We have earlier elucidated a pathway for the anticancer action of plant polyphenolic compounds against malignant cells involving mobilisation of endogenous copper ions and the consequent prooxidant action. To further confirm our hypothesis in vivo, we induced hepatocellular carcinoma (HCC) in rats by diethylnitrosamine (DEN). We show that in such carcinoma cells, there is a progressive elevation in copper levels at various intervals after DEN administration. Concurrently with increasing copper levels, epigallocatechin-3-gallate (EGCG; a potent anticancer plant polyphenol found in green tea) mediated DNA breakage in malignant cells is also increased. The cell membrane permeable copper chelator neocuproine inhibited the EGCG-mediated cellular DNA degradation, whereas the membrane impermeable chelator bathocuproine was ineffective. Iron and zinc specific chelators desferoxamine mesylate and histidine, respectively, were also ineffective in inhibiting EGCG mediated DNA breakage. Through the use of specific scavengers, the mechanism of DNA breakage was determined to be mediated by reactive oxygen species. In summary, we provide an in vivo evidence of accumulating copper in hepatocellular carcinoma that is targeted by EGCG, leading to its anticancer role in a prooxidant manner. Our findings confirm a novel mechanism of anticancer activity of EGCG in particular and plant derived nutraceuticals in general.


Copper Diethylnitrosamine EGCG Hepatocellular carcinoma Liver 


Conflicts of interest



  1. 1.
    Roguljic A, Roth A, Kolari CK, Maricic Z. Iron, copper, and zinc liver tissue levels in patients with malignant lymphomas. Cancer. 1980;46:565–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Kuo HW, Chen SF, Wu CC, Chen DR, Lee JH. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res. 2002;89:1–11.CrossRefPubMedGoogle Scholar
  3. 3.
    Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res. 2006;114:41–53.CrossRefPubMedGoogle Scholar
  4. 4.
    Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35:32–46.CrossRefPubMedGoogle Scholar
  5. 5.
    Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 2009;69:1712–6.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, et al. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis. 2014;35:415–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Hadi SM, Asad SF, Singh S, Ahmad A. Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life. 2000;50:167–71.CrossRefPubMedGoogle Scholar
  8. 8.
    Bryan SE. Metal ions in biological systems. New York: Marcel Dekker; 1979.Google Scholar
  9. 9.
    Kagawa TF, Geierstanger BH, Wang AH, Ho PS. Covalent modification of guanine bases in double-stranded DNA. The 1.2-A Z-DNA structure of d(CGCGCG) in the presence of CuCl2. J Biol Chem. 1991;266:20175–84.PubMedGoogle Scholar
  10. 10.
    Hadi SM, Bhat SH, Azmi AS, Hanif S, Shamim U, Ullah MF. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin Cancer Biol. 2007;17:370–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001;2:589–98.CrossRefPubMedGoogle Scholar
  12. 12.
    Ahmad A, Farhan Asad S, Singh S, Hadi SM. DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation. Cancer Lett. 2000;154:29–37.CrossRefPubMedGoogle Scholar
  13. 13.
    Ahmad A, Syed FA, Singh S, Hadi SM. Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. Toxicol Lett. 2005;159:1–12.CrossRefPubMedGoogle Scholar
  14. 14.
    Shamim U, Hanif S, Ullah MF, Azmi AS, Bhat SH, Hadi SM. Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanism. Free Radic Res. 2008;42:764–72.CrossRefPubMedGoogle Scholar
  15. 15.
    Ullah MF, Shamim U, Hanif S, Azmi AS, Hadi SM. Cellular DNA breakage by soy isoflavone genistein and its methylated structural analogue biochanin A. Mol Nutr Food Res. 2009;53:1376–85.CrossRefPubMedGoogle Scholar
  16. 16.
    Hadi SM, Ullah MF, Azmi AS, Ahmad A, Shamim U, Zubair H, et al. Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer. Pharm Res. 2010;27:979–88.CrossRefPubMedGoogle Scholar
  17. 17.
    Khan HY, Zubair H, Ullah MF, Ahmad A, Hadi SM. Oral administration of copper to rats leads to increased lymphocyte cellular DNA degradation by dietary polyphenols: implications for a cancer preventive mechanism. Biometals. 2011;24:1169–78.CrossRefPubMedGoogle Scholar
  18. 18.
    Zubair H, Khan HY, Sohail A, Azim S, Ullah MF, Ahmad A, et al. Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. Cell Death Dis. 2013;4, e660.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Khan HY, Zubair H, Faisal M, Ullah MF, Farhan M, Sarkar FH, et al. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action. Mol Nutr Food Res. 2014;58:437–46.CrossRefPubMedGoogle Scholar
  20. 20.
    Ullah MF, Ahmad A, Zubair H, Khan HY, Wang Z, Sarkar FH, et al. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol Nutr Food Res. 2011;55:553–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Hassan I, Chibber S, Khan AA, Naseem I. Riboflavin ameliorates cisplatin induced toxicities under photoillumination. PLoS One. 2012;7, e36273.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ramanathan R, Das NP, Tan CH. Effects of gamma-linolenic acid, flavonoids, and vitamins on cytotoxicity and lipid peroxidation. Free Radic Biol Med. 1994;16:43–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184–91.CrossRefPubMedGoogle Scholar
  24. 24.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res. 2003;23:1747–53.PubMedGoogle Scholar
  25. 25.
    Bialecki ES, Di Bisceglie AM. Diagnosis of hepatocellular carcinoma. HPB (Oxford). 2005;7:26–34.CrossRefGoogle Scholar
  26. 26.
    Trivanovic D, Petkovic M, Stimac D. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer. 2007;109:2623–4.CrossRefPubMedGoogle Scholar
  27. 27.
    Khan HY, Zubair H, Ullah MF, Ahmad A, Hadi SM. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Curr Drug Targets. 2012;13:1738–49.CrossRefPubMedGoogle Scholar
  28. 28.
    Quinlan GJ, Gutteridge JM. Oxygen radical damage to DNA by rifamycin SV and copper ions. Biochem Pharmacol. 1987;36:3629–33.CrossRefPubMedGoogle Scholar
  29. 29.
    Smith C, Halliwell B, Aruoma OI. Protection by albumin against the pro-oxidant actions of phenolic dietary components. Food Chem Toxicol. 1992;30:483–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Xie H, Kang YJ. Role of copper in angiogenesis and its medicinal implications. Curr Med Chem. 2009;16:1304–14.CrossRefPubMedGoogle Scholar
  31. 31.
    Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439–58.CrossRefPubMedGoogle Scholar
  32. 32.
    Arner E, Forrest AR, Ehrlund A, Mejhert N, Itoh M, Kawaji H, et al. Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS One. 2014;9, e80274.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Raffoul JJ, Kucuk O, Sarkar FH, Hillman GG. Dietary agents in cancer chemoprevention and treatment. J Oncol. 2012;2012:749310.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Chen ZP, Schell JB, Ho CT, Chen KY. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 1998;129:173–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Michels G, Watjen W, Weber N, Niering P, Chovolou Y, Kampkotter A, et al. Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology. 2006;225:173–82.CrossRefPubMedGoogle Scholar
  36. 36.
    Tyagi A, Gu M, Takahata T, Frederick B, Agarwal C, Siriwardana S, et al. Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res. 2011;17:5402–11.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, et al. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med. 2002;33:387–98.CrossRefPubMedGoogle Scholar
  38. 38.
    Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 2008;269:269–80.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Govindaraju M, Shekar HS, Sateesha SB, Vasudeva Raju P, Sambasiva Rao KR, Rao KSJ, et al. Copper interactions with DNA of chromatin and its role in neurodegenerative disorders. J Pharm Anal. 2013;3:354–9.CrossRefGoogle Scholar
  40. 40.
    Pryor WA. Why is the hydroxyl radical the only radical that commonly adds to DNA? Hypothesis: it has a rare combination of high electrophilicity, high thermochemical reactivity, and a mode of production that can occur near DNA. Free Radic Biol Med. 1988;4:219–23.CrossRefPubMedGoogle Scholar
  41. 41.
    Mohan A, Narayanan S, Sethuraman S, Krishnan UM. Combinations of plant polyphenols & anti-cancer molecules: a novel treatment strategy for cancer chemotherapy. Anti Cancer Agents Med Chem. 2013;13:281–95.CrossRefGoogle Scholar
  42. 42.
    Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346–52.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013;3:120144.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Chen D, Dou QP. New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer. Expert Opin Ther Targets. 2008;12:739–48.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Merlot AM, Kalinowski DS, Richardson DR. Novel chelators for cancer treatment: where are we now? Antioxid Redox Signal. 2013;18:973–1006.CrossRefPubMedGoogle Scholar
  46. 46.
    Colotti G, Ilari A, Boffi A, Morea V. Metals and metal derivatives in medicine. Mini Rev Med Chem. 2013;13:211–21.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Mohd Farhan
    • 1
  • Asim Rizvi
    • 1
    • 2
  • Imrana Naseem
    • 1
  • S. M. Hadi
    • 1
  • Aamir Ahmad
    • 3
  1. 1.Department of Biochemistry, Faculty of Life SciencesAMUAligarhIndia
  2. 2.Section of Radiobiology, Department of Radiology, The Biomedical Research TowerThe Ohio State UniversityColumbusUSA
  3. 3.Karmanos Cancer InstituteWayne State UniversityDetroitUSA

Personalised recommendations